In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Start-Up Previews, January 2014

Executive Summary

This Month's Profile Group, New Technologies Drive Growth In Orthopedic Extremities, features profiles of Cartiva, Conventus Orthopaedics, and Nextremity Solutions. Plus these Start-Ups Across Health Care: Arvinas, Flower Orthopedics, ImmunGene, and NeuroRecovery Technologies.

You may also be interested in...



Cartiva Inc.

The Cartiva synthetic cartilage implant from Cartiva Inc. is mostly water; hence, the hydrogel polymer mimics physical properties of human cartilage. The company is initially focusing on repairing cartilage defects in ankles and feet, specifically the metatarsophalangeal joint at the base of the great toe, to relieve arthritis pain.

Nextremity Solutions Inc.

Nextremity Solutions Inc. is focusing on devices for the forefoot – treatments for hammertoes and bunions, for example – which, with a projected growth rate of 13% is the fastest growing sector of the foot and ankle market and one of the fastest growing in orthopedic surgery.

Conventus Orthopaedics Inc.

Entering a market dominated by invasive metal plates and screws, the founders of Conventus Orthopaedics Inc., who came from the cardiovascular industry, have adapted the concept of minimally invasive self-expanding stents to the problem of treating distal radius fractures, the most common fracture of the forearm.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1133990

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel